Selapro 45 mg Spot-on Solution for Cats (2.6–7.5 kg)
Selapro 45 mg Spot-on Solution for Cats (2.6–7.5 kg)
Authorised
- Selamectin
Product identification
Medicine name:
SELAPRO 45 mg spot-on solution for cats (2.6–7.5 kg)
Selapro 45 mg Spot-on Solution for Cats (2.6–7.5 kg)
Active substance:
- Selamectin
Target species:
-
Cat
Route of administration:
-
Spot-on use
Product details
Active substance and strength:
-
Selamectin45.00/milligram(s)1.00Pipette
Pharmaceutical form:
-
Spot-on solution
Withdrawal period by route of administration:
-
Spot-on use
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AA05
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
United Kingdom (Northern Ireland)
Package description:
- The veterinary medicinal product is supplied in single dose pipettes which are moulded from a film composed of 3 layers: apolypropylene/COC/polypropylene, solvent free lacquer laminate and a copolymer of polyethylene/EVOH/polyethylene. Thepipettes are sealed within a child resistant 4-ply foil sachet composed of LDPE/nylon/aluminium foil/polyester film andpresented in an outer box.The products are supplied in boxes of 1 unit dose pipettes.
- The veterinary medicinal product is supplied in single dose pipettes which are moulded from a film composed of 3 layers: apolypropylene/COC/polypropylene, solvent free lacquer laminate and a copolymer of polyethylene/EVOH/polyethylene. Thepipettes are sealed within a child resistant 4-ply foil sachet composed of LDPE/nylon/aluminium foil/polyester film andpresented in an outer box.The products are supplied in boxes of 3 unit dose pipettes.
- The veterinary medicinal product is supplied in single dose pipettes which are moulded from a film composed of 3 layers: apolypropylene/COC/polypropylene, solvent free lacquer laminate and a copolymer of polyethylene/EVOH/polyethylene. Thepipettes are sealed within a child resistant 4-ply foil sachet composed of LDPE/nylon/aluminium foil/polyester film andpresented in an outer box.The products are supplied in boxes of 4 unit dose pipettes.
- The veterinary medicinal product is supplied in single dose pipettes which are moulded from a film composed of 3 layers: apolypropylene/COC/polypropylene, solvent free lacquer laminate and a copolymer of polyethylene/EVOH/polyethylene. Thepipettes are sealed within a child resistant 4-ply foil sachet composed of LDPE/nylon/aluminium foil/polyester film andpresented in an outer box.The products are supplied in boxes of 6 unit dose pipettes.
- The veterinary medicinal product is supplied in single dose pipettes which are moulded from a film composed of 3 layers: apolypropylene/COC/polypropylene, solvent free lacquer laminate and a copolymer of polyethylene/EVOH/polyethylene. Thepipettes are sealed within a child resistant 4-ply foil sachet composed of LDPE/nylon/aluminium foil/polyester film andpresented in an outer box.The products are supplied in boxes of 24 unit dose pipettes.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Norbrook Laboratories Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Manufacturing Limited
- Norbrook Laboratories Limited
Responsible authority:
- The Veterinary Medicines Directorate
Authorisation number:
- Vm 02000/4428
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0391/002
Concerned member states:
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
How useful was this page?:
